SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689813-21-000090
Filing Date
2021-05-10
Accepted
2021-05-10 17:25:53
Documents
85
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bhvn-20210331.htm   iXBRL 10-Q 1519781
2 EX-31.1 a2021q1bhvn10-qexhibit311.htm EX-31.1 10720
3 EX-31.2 a2021q1bhvn10-qexhibit312.htm EX-31.2 10934
4 EX-32.1 a2021q1bhvn10-qexhibit321.htm EX-32.1 7754
  Complete submission text file 0001689813-21-000090.txt   8905339

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20210331.xsd EX-101.SCH 81110
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20210331_cal.xml EX-101.CAL 101330
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20210331_def.xml EX-101.DEF 441637
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20210331_lab.xml EX-101.LAB 827566
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20210331_pre.xml EX-101.PRE 607585
10 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20210331_htm.xml XML 1464820
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 21908608
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences